PHARMACIELO LTD (PCLO.CA) Stock Price, Forecast & Analysis
TSX-V:PCLO • CA71716K1012
PCLO.CA Key Statistics, Chart & Performance
The current stock price of PCLO.CA is 0.07 CAD. In the past month the price decreased by -33.33%. In the past year, price decreased by -36.36%.
PCLO.CA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to PCLO.CA. When comparing the yearly performance of all stocks, PCLO.CA is a bad performer in the overall market: 82.41% of all stocks are doing better.
PCLO.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PCLO.CA. PCLO.CA may be in some trouble as it scores bad on both profitability and health.
PCLO.CA Financial Highlights
Over the last trailing twelve months PCLO.CA reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 57.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -74.31% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PCLO.CA Forecast & Estimates
PCLO.CA Ownership
PCLO.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.37 | 2.952B | ||
| GSD | DEVONIAN HEALTH GROUP INC | N/A | 1.991B | ||
| CRON | CRONOS GROUP INC | 36.3 | 1.348B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.179B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 6.9 | 872.942M | ||
| GUD | KNIGHT THERAPEUTICS INC | 124.44 | 592.761M | ||
| WEED | CANOPY GROWTH CORP | N/A | 526.898M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 411.936M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 26.54 | 360.254M | ||
| TSND | TERRASCEND CORP | N/A | 287.235M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About PCLO.CA
Company Profile
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
Company Info
PHARMACIELO LTD
82 Richmond Street East
TORONTO ONTARIO M5C 2V6 CA
CEO: David Attard
Employees: 49
Phone: 14163158741.0
PHARMACIELO LTD / PCLO.CA FAQ
What does PHARMACIELO LTD do?
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The firm has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade dried cannabis flower, cannabis oil extracts and cannabis-related products sold in bulk to pharmaceutical companies and medicinal cannabis distributors globally. In Colombia, PharmaCielo Colombia is a fully licensed cultivator, producer, and distributor of both TetraHydroCannabinol and Cannabidiol medical cannabis. Ubiquo is a knowledge management and medical consultation system. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate.
Can you provide the latest stock price for PHARMACIELO LTD?
The current stock price of PCLO.CA is 0.07 CAD.
Does PHARMACIELO LTD pay dividends?
PCLO.CA does not pay a dividend.
What is the ChartMill rating of PHARMACIELO LTD stock?
PCLO.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the GICS sector and industry of PCLO stock?
PHARMACIELO LTD (PCLO.CA) operates in the Health Care sector and the Pharmaceuticals industry.
How is the valuation of PHARMACIELO LTD (PCLO.CA) based on its PE ratio?
PHARMACIELO LTD (PCLO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).
Can you provide the market cap for PHARMACIELO LTD?
PHARMACIELO LTD (PCLO.CA) has a market capitalization of 13.15M CAD. This makes PCLO.CA a Nano Cap stock.